Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

Seminars in Oncology

Volumn 28, Issue 6, 2001, Pages 565-569

  Munshi, Nikhil C ^a,b   Wilson, Carla ^a,b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; LACTATE DEHYDROGENASE; MELPHALAN; THALIDOMIDE; VASCULOTROPIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME 13; DRUG EFFICACY; HUMAN; MICROVASCULATURE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VASCULARIZATION;

EID: 0035207952     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(01)90025-9     Document Type: Article

References (29)

1. Plasma cell dyscrasias
2. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias
3. Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma
4. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
5. Angiogenesis in cancer, vascular, rheumatoid and other disease
6. Molecular mechanisms of developmental and tumor angiogenesis
7. Significance of angiogenesis in tumour progression and metastasis
8. Tumoural vascularity as a prognostic factor in cancer patients: The evidence continues to grow
9. Angiogenic factors
10. Tumour angiogenesis
11. Neovasculature induced by vascular endothelial growth factor is fenestrated
12. Vascular endothelial growth factor and its receptors
13. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
14. Are angiostatin and endostatin cures for cancer?
15. Angiogenesis and tumor metastasis
16. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
17. Bone marrow angiogenesis and progression in multiple myeloma
18. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies
19. Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44
20. Angiogenesis under normal and pathological conditions
21. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
22. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
23. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
24. Molecular and biological properties of the vascular endothelial growth factor family of proteins
25. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
26. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
27. Antitumor activity of thalidomide in refractory multiple myeloma
28. Low-dose thalidomide seems to be effective in multiple myeloma
29. Thalidomide-A revival story